Clinical Development

Proof Assets

Clinical Development

Proof Assets

Real world experience backed by extensive research

UNLOCK THE POWER OF INNOVATION WITH AVITA MEDICAL’S GROUNDBREAKING RECELL SYSTEM

As a pioneer in regenerative technology, AVITA Medical is dedicated to elevating patient care in skin restoration, addressing critical unmet medical needs. Our commitment is underscored by a comprehensive approach that combines real-world experience with rigorous research. As you explore the resources we’ve gathered – including abstracts, videos, and publications – you’ll discover the impressive successes and transformative potential of the RECELL® System. Delve into a wealth of evidence that supports the system’s efficacy in diverse applications, from acute thermal burns to full-thickness skin defects, traumatic wounds, vitiligo, and more. This wealth of knowledge cements our confidence as we progress towards expanding the system’s impact through ongoing clinical trials.

Publications
Videos
Health Economics

Burns

 

Holmes et al. J Burn Care Res.

A Comparative Study of the RECELL ®  Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries.

2018 Aug 17;39(5):694-702.

Holmes et al. J Burn Care Res.

Demonstration of the Safety and Effectiveness of Autologous Skin Cell Suspension Combined with Meshed Skin Grafts for the Reduction of Donor Area in the Treatment of Acute Burns.

2018 Apr 39; Suppl 1: S60.

Holmes et al. Burns.

Demonstration of the safety and effectiveness of the RECELL ®  System combined with split-thickness meshed autografts for the reduction of donor skin to treat mixed-depth burn injuries.

2019 Jun;45(4):772-782. doi: 10.1016/j.burns.2018.11.002.

Sood et. al. Wounds.

A comparative study of spray keratinocytes and autologous meshed split-thickness skin graft in the treatment of acute burn injuries.

2015 Feb:27(2):31-40.

Gravante et. al. Burns.

A randomized trial comparing RECELL ®  System of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns.

2007;33(8):966-72

Lim et. al. Burns.

Is the length of time in acute burn surgery associated with poorer outcomes?

2014;40(2):235-40.

Kowal et al. Adv Ther.

Cost-Effectiveness of the Use of Autologous Cell Harvesting Device Compared to Standard of Care for Treatment of Severe Burns in the United States.

2019 May 7. doi: 10.1007/s12325-019-00961-2.

Foster et al. J of Current Medical Research and Opinion.

Evaluating Health Economic Outcomes of Autologous Skin Cell Suspension (ASCS) for Definitive Closure in US Burn Care Using Contemporary Real-World Burn Center Data.

Nov 2021. 4(11), 1042-1054.

Carter et al. J Burn Care Res.

Evaluating Real-World National and Regional Trends in Definitive Closure in U.S. Burn Care: A Survey of U.S. Burn Centers.

July 2021.

Carter et al. J Burn Care Res

ASCS treatment impact on length of stay data and costs for patients with small burns.

2022 April 43; Suppl 1: S61.

RECELL® System – Case Study 029: Epidermal Regeneration for Facial Burn

Dr. Carter describes outcomes of an adult patient treated with RECELL alone for a deep partial-thickness 11% TBSA flame burn on the face.

RECELL® System – Case Study 039: Treatment of a Deep Partial-Thickness Facial Burn

Dr. Sood describes outcomes for an adult patient treated with RECELL alone for a deep partial-thickness 7% TBSA scald burn on the face.

RECELL® System – Case Study 040: Re-Pigmentation of a Burn Injury to the Posterior Torso

Dr. Sood describes outcomes for an adult patient treated with RECELL alone for a deep partial-thickness 20% TBSA burn on the torso.

RECELL® System – Case Study 041: Pediatric Full-Thickness Case with >50% TBSA

Drs. Carter and Holmes describe treatment of a pediatric patient with RECELL in combination with a 4:1 split thickness skin graft and 3:1 split thickness skin graft and Integra dermal regeneration template for a 58% TBSA full-thickness burn.

 

RECELL System Health Economics Study Summary